29 Oct 2026 03:00:12
Oct 29 (Reuters)-
ONO PHARMACEUTICAL
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Sep 30, 2026 Sep 30, 2025 Mar 31, 2027
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 232.50 257.14 455.00
(-9.6 pct) (+7.0 pct) (-11.8 pct)
Operating 57.91 52.07 94.00
(+11.2 pct) (+6.7 pct) (+1.9 pct)
Pretax 58.42 52.18 94.00
(+12.0 pct) (+9.7 pct) (+1.5 pct)
Net 44.93 40.09 71.00
(+12.1 pct) (+7.1 pct) (+1.8 pct)
EPS Basic 95.60 yen 85.33 yen 151.09 yen
EPS Diluted 95.49 yen 85.28 yen --
Ann Div -- 80.00 yen 80.00 yen
-Q2 div 40.00 yen 40.00 yen --
-Q4 div -- 40.00 yen 40.00 yen
NOTE - ONO PHARMACEUTICAL.
(Figures are reported based on international accounting rules (IFRS).)
If there is no Q1 or Q3 dividend, Q2 will in most cases correspond to the first-half
dividend and Q4 to the second-half dividend announced before a new corporate law in
2006 allowed companies to pay and report dividends on a quarterly basis.
*Net - represents Net profit attributable to owners of the parent company.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4528.T